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Abstract
The cascade of molecular events involved in mammalian sex determination has been shown to involve the SRY gene, but
specific downstream events have eluded researchers for decades. The current study identifies one of the first direct
downstream targets of the male sex determining factor SRY as the basic-helix-loop-helix (bHLH) transcription factor TCF21.
SRY was found to bind to the Tcf21 promoter and activate gene expression. Mutagenesis of SRY/SOX9 response elements in
the Tcf21 promoter eliminated the actions of SRY. SRY was found to directly associate with the Tcf21 promoter SRY/SOX9
response elements in vivo during fetal rat testis development. TCF21 was found to promote an in vitro sex reversal of
embryonic ovarian cells to induce precursor Sertoli cell differentiation. TCF21 and SRY had similar effects on the in vitro sex
reversal gonadal cell transcriptomes. Therefore, SRY acts directly on the Tcf21 promoter to in part initiate a cascade of
events associated with Sertoli cell differentiation and embryonic testis development.
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Introduction
Mammalian embryos have bipotential gonads which can
develop into either a testis or an ovary depending on paternal
and maternal chromosomal contributions. Paternal transmi-
ssion of a Y chromosome triggers testicular differentiation,
whereas the contribution of paternal X chromosome results in
ovarian differentiation. The bipotential gonad contains a pool of
undifferentiated somatic cell precursors that during development
differentiate into either testicular (Sertoli, Leydig, and peritubular
myoid) or ovarian (theca and granulosa) somatic cells in response
to extrinsic and intrinsic factors. The gene for the transcription
factor Sry is located on the Y chromosome and is sufficient to
induce testis fate in the bipotential gonad [1,2,3]. The nuclear
orphan receptor steroidogeneic factor 1 SF1 and SRY coopera-
tively upregulate an immediate downstream gene Sox9 through an
interaction on its testis-specific enhancer [4]. Subsequently, SOX9
regulates the differentiation of precursor cells into the Sertoli
cells. SOX9 expressed by Sertoli cells cooperates with FGF9 and
prostaglandins [5,6] to promote testis development. Somatic
cells undergo dramatic molecular interactions during gonadal
sex differentiation to ultimately influence the differentiation of
germ cells. Several sex-specific genes have been shown to inter-
act during the differentiation of gonads. For example, SRY,
SOX9, FGF9, and prostaglandins have an important role in the
differentiation of Sertoli cells and testis. In contrast, RSPO1,
WNT4, beta-catenin, and FOXL2 antagonize SOX9 and FGF9
to promote ovarian differentiation [4,7,8]. Despite extensive efforts
made to uncover the molecular mechanisms underlying sex
determination in mammals, the downstream target genes of SRY
remain poorly understood.
The process of sex determination starts with differentiation of
somatic cells. Since SRY binds to HMG box sequences on the
DNA, the cell fate associated genes containing HMG box binding
sites in their promoter are considered potential downstream
target candidates. Numerous cell type-restricted basic helix-loop-
helix (bHLH) transcription factors have been identified and
shown to control cell fate specification, differentiation and
morphogenesis during development [9,10,11]. Some bHLH
genes function early in embryonic development and influence a
wide variety of tissues, while others act later in development and
are required in the adult cells to maintain cellular differentiation.
In our previous microarray analysis, a bHLH gene Tcf21 (also
called, bHLHa23, Pod1, capsulin, epicardin) was found to be
highly expressed in the gonads coinciding with the expression of
SRY and SOX9 [12]. A genome wide phylogenetic classification
of the entire bHLH gene family has recently developed a uniform
nomenclature with Tcf21 named as bHLHa23 and put it in
perspective to other species [11,13]. Tcf21 null mutants exhibit
male-to-female sex reversal with some germs cells entering
meiosis [14]. An analysis of human, mice and rat Tcf21
promoters showed at least three global SRY-binding sites within
a 2 kb promoter region. Therefore we hypothesize that SRY
interacts with Tcf21 to promote somatic cell differentiation during
male gonadal sex determination. Observations demonstrate Tcf21
is a downstream target gene for SRY action and promotes Sertoli
cell development.
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Expression of Tcf21 gene and localization of the TCF21
protein in the rat embryonic testis
Tcf21 expression has been detected quite early in development
in the embryonic mesoderm, showing a similar pattern to Wt1 and
Gata4 [15]. In a microarray analysis with rat gonadal RNA [12],
relatively higher levels of Tcf21 transcripts were found at the
embryonic day 13 (E13) stage of testis development, after which
levels are maintained during this stage of development (Fig. 1). At
embryonic day 13, which is equivalent to the 13 to 18 tail somites
stage, TCF21 was localized to somatic cells adjacent to germ cells
(Fig. 2A). At E14, TCF21 immunopositive cells were found in the
Sertoli cells and at E16 in the interstitium including Leydig cells
(Fig. 2, B&D). As a positive control, AMH was used and localized
to Sertoli cells (Figure 2C). The differential localization of TCF21
protein at different times of sex determination suggests differential
functions at different periods of testis development. Expression
patterns of TCF21 in the E13 and E14 testes indicate a transient
role in Sertoli cell differentiation, whereas expression at E16 in the
interstitium suggests a role during later Leydig cell differentiation
[14,16].
Characterization of the rat Tcf21 promoter
Analysis of the Tcf21 promoter revealed three putative SRY
binding sites [17] in the 2 kb upstream region from the tran-
scription start site. A comparison was made of the genomic region
of the rat Tcf21 promoter with that of mouse and human (Fig. 3A).
SRY binding sites are conserved among human, mouse and rat.
There are multiple overlapping putative SRY binding sites in
mouse and rat promoters. Most of the SRY binding sites are
paired and separated by one or two nucleotides. In addition, the
rat Tcf21 promoter contained a binding site for SRY/SOX9 at
a 21.3 k upstream region and GATA 4 in multiple locations.
Multiple E-box binding sites are present within the 22k b
promoter regions.
SRY stimulates Tcf21 promoter activity in vitro
Primary cell cultures were derived from E13 testes, equivalent to
12–18 tail somite stage of male rat embryos, and used for
promoter reporter assays. Binding sites for SRY and SOX9 on the
Tcf21 promoter were investigated with site specific mutagenesis for
their ability to regulate the Tcf21 promoter. E13 cultures derived
from testicular primary cells or postnatal 20-day-old (P20) primary
Sertoli cells were co-transfected with an Sry expression plasmid
together with different Tcf21 promoter fragments in a luciferase
reporter system. Similar results were obtained from both E13 testis
cultures or purified Sertoli cell cultures. The longer promoter
constructs had lower luciferase activity (Figure 3B). Interestingly,
over-expression of rat SRY (Figure 3D), mouse SRY, mouse
SOX9 and human SRY (data not shown) resulted in an increased
activation of the Tcf21 promoter (Figure 3D). Point mutations of
SRY motifs significantly perturbed promoter activity (Fig. 3C and
D). Mutation of one of the three SRY binding sites did not result
in significant change in promoter activity, while mutation of two
binding sites significantly decreased the activity of the Tcf21
promoter. Observations suggest the requirements for having
at least two SRY binding sites for activating the promoter in vitro.
Overexpression of SRY increased the activity of the Tcf21 pro-
moter having paired SRY binding sites (Fig. 3D).
SRY recombinant protein binds Tcf21 promoter in vitro
The possibility that SRY binds to the defined SRY binding sites
on the fragment of the Tcf21 promoter was investigated. Reactions
were set up to bind HA tagged SRY-HA recombinant protein to
the Tcf21 promoter oligonucleotides with or without mutated SRY
binding sites followed by immunoprecipitation (IP) with anti-HA
antibody. Enriched fragments were analyzed by PCR with primers
flanking the binding sites (Fig. 4A). Affinity purified non-immune
mouse IgG was used as a negative control in the experiment. Anti-
HA antibody pulled down the oligonucleotide with intact SRY
binding sites, but not the one with mutated SRY binding sites
(Fig. 4A).
The specific SRY antibody developed by Dr. Peter Koopman’s
laboratory, Queensland University, Brisbane, Australia was shown
to bind SRY, but not SOX9 [6]. In order to validate a
commercially available anti-SRY (Santa Cruz, Santa Cruz CA)
antibody for ChIP assay, in vitro immunoprecipitation was
performed using recombinant SRY and SOX9 proteins. Enrich-
ment of target protein was detected by western blot using
antibodies against the HA tags for the recombinant proteins.
The commercial SRY antibody did pull down SRY, but did not
pull down SOX9 recombinant protein (Figure 4B). The SOX9
antibody recognized both SRY and SOX9 recombinant proteins
(Figure 4B). Therefore, the SRY antibody was specific for SRY
and thus used in the ChIP assay.
SRY binds in vivo to the Tcf21 promoter during male sex
determination
There has been little progress toward identifying in vivo
downstream targets of SRY. This is in part due to technical
limitations of procedures such as in vivo ChIP assay which
traditionally requires a large amount of starting material from
the embryonic testis. For example, a conventional ChIP assay
requires a large amount of chromatin which is equivalent to
pooled gonads of five to six hundred embryos [6,18]. The
techniques used in the present study overcome these technical
difficulties. The present study used a modified in vivo ChIP assay
with isolated testis samples from 20 to 25 testes at the 12 to 18 tail
somite stage of rat embryo development. The promoters of any
Figure 1. Embryonic gene expression in E13, E14 and E16
testis. Relative expression of Tcf21, Sry, Amh, Tcf12 transcript levels
obtained in microarray analysis in the testis of male rat at various stages
of embryonic gonadal development [12].
doi:10.1371/journal.pone.0019935.g001
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determination should be pulled down from the chromatin mixture
by anti-SRY antibody. To test whether SRY associates with a
fragment of Tcf21 promoter, PCR primers were designed to
amplify the Tcf21 promoter regions flanking an SRY binding site.
As a negative control, primers were designed to a promoter region
which did not contain any HMG box sites or putative SRY
binding sites. The SRY antibody obtained from Dr. Peter
Koopman, Brisbane, Australia, pulled down the fragment of
Tcf21 promoter containing the predicted SRY binding site, but not
the negative control region without its binding site (Fig. 4C). As a
positive control in the ChIP assay, anti GATA4 antibody was
Figure 2. Immunolocalization of TCF21 protein in embryonic testis. (A) TCF21 protein in somatic cells of the E13 testis (arrows). (B)
Localization of TCF21 protein in E14 testis. Insert shows magnified section of E14 testis. (C) AMH localization in E14 testis. AMH was stained with DAB,
so brown color represents Sertoli cells. (D) TCF21 protein in E16 testis (green). (E) AMH localization in E16 testis. Abbreviations: GC=Germ Cells.
SC=Sertoli Cells. LC=Interstitial cells. Dotted circles indicate testis cord structures. Data are representative of a minimum of three different
experiments.
doi:10.1371/journal.pone.0019935.g002
bHLH TCF21 Target of Sex Determining Gene SRY
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19935Figure 3. Tcf21 promoter mutagenesis analysis. (A) Analysis of mouse, rat and human Tcf21 promoter and SRY binding sites. Gonadal (testis) cell
culture and transfection assays with relative luciferase activity compared to wild type (WT) promoter presented. Bars with asterisks are significantly
different from 20.5 kb control promoter. (B) Promoter activity decreased with the length of the promoter. (C) Deletion of SRY binding motif and
relative promoter activity. (D) Over-expression of SRY in E13 male primary cells increase overall luciferase activity of the mutant promoter, except for
the mutant which lacks first uncoupled TAACAAA site (gray response element). Data are presented as the mean 6 SEM from a minimum of three
different experiments performed in replicate. The asterisks indicate (*) p,0.05, (**) p,0.01, (***) p,0.001 with a Student’s t-test.
doi:10.1371/journal.pone.0019935.g003
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PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19935Figure 4. SRY in vitro and in vivo binding to Tcf21. (A) Immunoprecipitation-based in vitro pulldown assay was designed to test the physical
binding of SRY protein with Tcf21 promoter SRY/SOX9 response element oligonucleotide. Recombinant SRY-HA tagged protein was bound in vitro to
250 bp Tcf21 promoter fragment containing three SRY binding sites. An anti-HA antibody immunoprecipitated a fragment of Tcf21 promoter
containing all three SRY-binding sites, whereas mutation of the bind site eliminated SRY binding. (B) Antibody specificity for validating in vivo ChIP
assay. Recombinant SRY and SOX9 immunoprecipitation with anti-SRY (Santa Cruz, CA) and anti SOX9 (Koopman) antibodies followed by western
blot with anti-HA antibody which was attached as a tag to those recombinant proteins. The SRY antibody specifically pulled down SRY, whereas SOX9
antibody recognized both SRY and SOX9. (C and D) In vivo carrier ChIP assay was performed using chromatin from the embryonic testis from E13
male embryos (14–18 tail somite stage). The anti-SRY antibody (Koopman) (C) and commercial anti-SRY antibody (Santa Cruz, CA) (D)
immunoprecipitated a fragment of Tcf21 promoter containing SRY binding sites, in vivo. Enriched DNA was amplified by primers flanking SRY binding
site and for non-specific enrichment PCR primers were designed between 20.7 and 20.9 kb promoter which did not contain any consensus binding
site for HMG box proteins (no Sry site). A control non-immune IgG (IgG) had no precipitation, while a positive control input DNA (Input) did have
Tcf21 PCR product. A positive control GATA4 antibody (GATA4) precipitation also pulled down a GATA4 site in Tcf21 promoter. (E) Over-expression of
TCF21 induced AMH expression in the E13 primary cells derived from embryonic ovaries. The TCF21 or SRY over-expression (TCF21) or (Sry) indicated,
along with controls (No Primer, No DNA, Water and Empty Plasmid), with positive PCR control of L19 gene (Positive). Data is representative of a
minimum of three different experiments.
doi:10.1371/journal.pone.0019935.g004
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regions of the Tcf21 promoter and were used as a positive control.
A ChIP assay for GATA4 was found to immunoprecipitate and
identify the in vivo Tcf21 promoter (Fig. 4C). The anti SRY from
Dr. Peter Koopman was previously shown to be specific for mouse
SRY and was found to pull down the Tcf21 promoter from
developing rat E13 gonads (Fig. 4C). A commercially available
anti SRY antibody (Santa Cruz, Santa Cruz, CA) was found to be
specific for SRY (Fig. 4B) and also pulled down the Tcf21
promoter in the ChIP assay from developing E13 testis (Fig. 4D).
Therefore, two different anti SRY antibodies in the ChIP assay
demonstrated that SRY directly binds the Tcf21 promoter during
male gonadal sex determination. Positive controls such as TESCO
which is considered a downstream target for SRY [4], has not
been characterized in the rat, so current study did not focus on
TESCO as a positive control. Instead we have initiated genome-
wide ChIP-Chip analysis of SRY targets in embryonic testis during
sex determination.
TCF21 promotes in vitro sex reversal of embryonic
ovarian cells to induce Sertoli differentiation
The above in vitro and in vivo results demonstrate that SRY
interacts with the Tcf21 promoter during male sex determination
and testis differentiation. Tcf21 expression level was similar to that
of Wt1 and Gata4 at E9.5 and E10.5 [15], whereas during male sex
determination transcripts for this gene remained elevated in the
rat. The homozygous knockout mutant for Tcf21 showed
abnormal gonadogenesis, lost testis cord structures, abnormal
vascular innervations into the testis, and reduced Sox9 expression
in the testis [14]. These results suggest that TCF21 is involved in
male sex determination and testis differentiation. An embryonic
E13 ovary culture system was used to test whether TCF21 can
promote in vitro sex reversal and the induction of the expression of
a male marker gene of testis differentiation. Expression plasmids
for Tcf21 or Sry were over-expressed in subcultures (less than 12) of
primary cell cultures derived from E13 rat ovaries. The objective
was to promote an in vitro sex reversal from an ovarian somatic cell
population to a testicular somatic cell population. TCF21 over-
expression induced the expression of anti Mu ¨llerian hormone
(AMH) which is a specific marker of Sertoli cell differentiation in
the embryonic testis, but not expressed by the embryonic ovary or
ovarian culture, Figure 4E. As expected, SRY over-expression in
the embryonic ovarian cells also induced AMH expression
(Figure 4E). This observation suggests that TCF21 promotes
embryonic Sertoli cell differentiation in a similar manner as SRY.
The cell culture transcriptomes were examined to assess the in
vitro sex reversal of the embryonic ovarian cell culture to a testis
cell differentiated state on a genome wide level. Microarray
analysis of the embryonic cell cultures were investigated in the
absence or presence of SRY, TCF21 or TCF21 with its potential
binding partner TCF12/REB-alpha. All bHLH transcription
factors dimerize and due to the high level of Tcf12 expression in
the embryonic testis (Figure 1), the combined actions of TCF21
and TCF12 were also assessed. TCF12 is also known as REB-
alpha which is somewhat ubiquitously expressed and a binding
partner of numerous bHLH factors [19]. Over-expression of SRY
in the embryonic ovary cell culture promoted a transcriptome
more similar to the testis with approximately 800 significantly
increased transcripts, Figure 5A. Interestingly, TCF21 also
promoted a transcriptome with approximately 20% overlap with
that induced by Sry, Figure 5A. The combined actions of TCF21
and TCF12 induced a more dramatic increase in AMH
expression, data not shown, and a transcriptome with overlap
with TCF21 and SRY, Figure 5. Observations support a potential
role for TCF12 as a potential partner for TCF21. A list of the
genes with the most highly increased expression induced by SRY
and TCF21 are presented in Table S1. An extended list of the
genes altered after TCF21, SRY or TCF21 and TCF12 over-
expression are presented in Table S2. Observations demonstrate
TCF21 and TCF12 promote some similarities in the in vitro sex
reversal transition in the transcriptome as SRY, supporting a role
of TCF21 as a downstream target of Sry during male gonadal sex
determination.
Discussion
Since the discovery of SRY as a master male sex determining
factor several efforts have been made to identify its downstream
target genes. Whether Sox9 is the only downstream gene that
carries out all functions necessary for initiating male sex
development or whether there are multiple SRY target genes that
cooperatively act to induce testis-specific somatic cell differentia-
tion remains to be determined. Recent developments suggest that
SRY and SF1 cooperatively activate Sox9 expression through
interactions with its enhancer region, confirming Sox9 as one of the
SRY target genes [4] (Figure 6). The SRY protein has been shown
to interact in vivo with the promoter enhancer region of the
Cerebellin 4 precursor gene (Cbln4), which is present in Sertoli cells
during early embryonic development [18] (Figure 6). Although,
the exact function of Cbln4 gene in testis differentiation is not
clearly understood yet, this gene has been suggested as one of the
downstream target genes of SRY. Using a similar approach to that
taken in the current study we have found SRY directly interacts
and regulates the promoter for neurotrophin 3 (Ntf3) [20], that has
previously been suggested to have a critical role in testis cord
formation [21,22] (Figure 6). A major hindrance in finding SRY
target genes is the technical limitation to in vivo chromatin
immunoprecipitation (ChIP) methods. Using an in vivo carrier
ChIP method the current study demonstrates that SRY interacts
with the bHLH family transcription factor Tcf21 during male sex
determination. Observations provide insights into the mechanism
of SRY regulation of Sertoli cell differentiation and the factors
regulating (e.g. TCF21) cell differentiation during male gonadal
sex determination.
Numerous cell type-restricted basic helix-loop-helix (bHLH)
transcription factors have been identified and shown to control cell
fate specification, differentiation and morphogenesis during
embryonic development, while others act later in development
and are required in the adult cells to maintain cellular
differentiation. Examples include MESP in heart cell differentia-
tion, MYOD in muscle differentiation, and Neurogenin in neuron
differentiation [23,24,25]. In an embryonic rat and mouse testis
microarray Tcf21 was found as one of the most highly expressed
transcription factor genes [12], Figure 1. The presence of TCF21
protein in the somatic cells of the embryonic testis was confirmed
immunohistochemically. Nuclear localization of TCF21 was
observed in the Sertoli cell in testis of the E13 and E14 testis,
whereas it appeared in the interstitial cells in E16 testis suggesting
it has multiple functions during testis differentiation. Prior to male
sex determination Tcf21 mRNA is localized in the gonadal ridges
and its expression pattern was found to be similar to Wt1 and
Gata4 [15]. Gene knockout studies suggested that Tcf21 null
mutant male mice were partially sex-reversed [14]. Combined
observations suggest Tcf21 has multiple roles in male sex
determination and testis morphogenesis.
Most of the genes that are highly expressed during the period of
male sex determination have SRY or SOX9 binding sites in their
promoters [17]. Since the Tcf21 promoter harbors three SRY
bHLH TCF21 Target of Sex Determining Gene SRY
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that SRY may bind these response elements and regulate the
activity of the core promoter. Over-expression of SRY in the
primary embryonic testis cell culture increased the Tcf21 promoter
activity. This Tcf21 promoter activity was significantly reduced
when all three SRY binding sites were mutated. SRY seemed to be
able to activate the Tcf21 promoter if any two of the three binding
sites were intact. An oligonucleotide pull-down assay was used to
confirm SRY directly binds to the Tcf21 promoter SRY binding
sites (Figure 4A). Although these in vitro promoter actions and
binding studies support a potential role for SRY regulation of
Tcf21, SOX9 can have similar activities and a direct role of SRY is
uncertain in vivo. An example of a gene that has similar in vitro
observations, but was found in vivo to primarily respond to SOX9 is
prostaglandin synthase (PGDS) [6] (Figure 6). To investigate the
potential direct SRY binding to the Tcf21 promoter in vivo a ChIP
assay with chromatin samples from embryonic testis undergoing
sex determination and cellular differentiation was performed. The
major limitation in running ChIP assays with embryonic gonad
samples is the amount of chromatin required. This limitation has
hindered efforts made to find downstream target genes of SRY.
The current study adopted the ChIP protocol developed by
O’Neill et al (2006) [26] and modified to meet conditions with
rat SRY protein. Observations demonstrate a ChIP with SRY
antibody immunoprecipitated from embryonic testes the Tcf21
gene promoter. Tcf21 appears to be one of the downstream target
genes of SRY. To identify other SRY target genes an SRY ChIP is
currently being subjected to ChIP-Chip whole genome promoter
tiling arrays.
Tcf21 null mutants have several testis phenotypes [14]
suggesting multiple roles for TCF21 in testis organogenesis.
Tcf21 was over-expressed in primary embryonic ovarian cells
derived from 15 tail somite stage female embryos (E13) to in-
vestigate the actions of TCF21. Tcf21 over-expression induced
Amh expression in the female cells and so provided evidence of its
role in the induction of testis somatic cell differentiation
Figure 5. Transcriptome analysis of SRY and TCF21 actions. Venn diagram (A) with overlap of total gene sets (p,0.05) altered in response to
various expression constraints (Sry, Tcf21, Tcf21 plus Tcf12, Tcf12). Total genes in the gene sets and overlap numbers are presented. These gene sets
are statistically significant increase genes, but with no further cut-off parameters. (B) Restricted gene sets overlapped in female E13 cultures involving
gene sets with altered expression with .1.2 fold change, p,0.05, and mean difference .10.
doi:10.1371/journal.pone.0019935.g005
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development, but Sertoli cells in the embryonic testis do express
Amh. In contrast, Tcf21 null mutants did not completely lack
SOX9 and AMH expression because the loss of TCF21 was likely
compensated for by yet undefined tissue specific binding partners.
This phenomenon has been seen for heart muscle differentiation
in Mesp1 mutants [23,27] and prostate differentiation in NCoA1
mutants [28]. The over-expression of Tcf21 in the fetal ovarian
cell culture promoted an SRY-like transcriptome and cellular
differentiation similar to normal testis development. SRY and
TCF21 both induced similarities in the transcriptomes and in vitro
gonadal sex reversal in the ovarian cell culture. The group of
specific genes identified will be useful to consider in further
elucidation of the cascade of gene expression in testis differenti-
ation. In addition to the identification of the in vitro and in vivo
association of SRY with the Tcf21 promoter, a functional role of
TCF21 in promoting in vitro sex reversal and a SRY-like gene
expression profile was observed.
A distinct function of TCF21 in testis differentiation is as-
sociated with fetal Leydig cell differentiation. Excessive prolifer-
ation of P450SCC and SF1 expressing cells were observed in the
gonads of Tcf21 null mice [29]. TCF21 expression allows fetal
Leydig cells to maintain stem cell like characteristics. These results
can be explained by observations that TCF21 suppresses SF1,
NOTCH1 and hedgehog signaling which are required for dif-
ferentiation of fetal Leydig cells [16,30]. In the rat we observed
differential immunolocalization of TCF21 during male sex de-
termination and testis differentiation. At the onset of sex deter-
mination when SRY is critical for the induction of Sertoli cell fate
determination, TCF21 is primarily localized to Sertoli cells during
testis cord formation (E13–E14). Later in testis differentiation as
the interstitial cells and Leydig cell differentiation is initiated the
TCF21 is primarily localized in Leydig cells (E16). Therefore,
TCF21 has a transient role in the initial differentiation of Sertoli
cells in response to SRY, and then a later role in the initiation of
Leydig cell differentiation. The hypothesis is that TCF21 likely
promotes a cascade of other factors, such as bHLH proteins, to
continue the subsequent differentiation.
Combined in vitro and in vivo observations have demonstrated
that TCF21 is a downstream target of SRY and plays an
important role in testis differentiation (Figure 6). Our results also
provide insights into the possibility for bHLH protein involvement
in Sertoli and Leydig cell differentiation. Since bHLH transcrip-
tion factors have a critical role in the differentiation of many tis-
sues and cell types, a role in mammalian sex determination and
gonadal cell differentiation will be an interesting future area of
research. Experiments are in progress to determine the cascade of
genes following TCF21 and SRY expression and their roles in
testis differentiation and male sex determination.
Materials and Methods
Tissue preparation and Histology
Harlan Sprague-Dawley rats were kept in a temperature
controlled environment and given food and water ad libitum. Estrous
cycles of female rats were monitored by cellular morphology from
vaginal smears [31]. Rats in early estrus were paired with males
overnight and mating confirmed by sperm positive smears, denoted
day0 ofpregnancy. Pregnantratswere euthanized atE13, E14, and
E16 of pregnancy, and embryonic gonads were collected for
histological analysis. Sex was determined by PCR using primers
specific for Sry on genomic DNA isolated from embryo tails as
previously described [32]. All procedures were approved by the
Washington State University Animal Care and Use Committee
(IACUC approval # 02568-018). Tissue specimens were fixed in
Bouin’s solution for 1 h and embedded in paraffin using standard
procedures. Serial sections of 4 mm were stained with hematoxylin
and eosin (H&E) using standard procedures [33].
Immunohistochemistry
Embryonic testis sections [34] were deparaffinized, rehydrated
through a graded ethanol series, boiled 10 minutes in 10 mM
sodium citrate buffer to expose the antigens, washed with 0.1%
Triton-X solution, and then blocked with 10% serum of the
species secondary antibody was raised in for 30 min prior to
incubation with 0.5 mg/ml primary rabbit anti-TCF21 antibody
for 18 h (ABcam). The sections were then washed with PBS and
incubated with 1:3000 diluted Alexa Fluor 488 labeled secondary
antibody for 45 min (goat anti-rabbit IgG; Invitrogen, Eugene,
OR). Slides were mounted with Vecta-Shield plus DAPI (Vector
Laboratories Inc.), sealed with coverslips, and analyzed using
fluorescence confocal microscopy (Zeiss). Negative control exper-
iments were performed using a non-immune IgG at 0.5 mg/ml
(rabbit IgG; Sigma, St. Louis, Mo). AMH localization was
Figure 6. Summary of SRY downstream genes. Proposed downstream actions of SRY on Sox9 and Tcf21 genes, along with Clbn4, Ntf3, and
others yet to be identified. TCF21 induction of Sertoli cell differentiation and expression of marker genes such as Amh indicated. Combined actions of
SRY and SF1 on Sox9 expression and actions on Fgf9 and Pgds expression indicated.
doi:10.1371/journal.pone.0019935.g006
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(R&D Systems, Minneapolis, MN) and 1:3000 diluted Alexa Fluor
488 labeled secondary antibody (donkey anti-goat IgG; Invitrogen,
Eugene, OR) using the protocol above. Non-fluorescent staining
was performed using DAB staining method.
Reporter Plasmid Preparation
All the primers used in plasmid preparation are listed in the
Table S3. In order to prepare Tcf21 promoter/reporter vectors,
different size fragments (22.7 k, 21.9 k, 21.7 k, 21.6 k, and
20.5 k) of the rat genomic DNA upstream of the coding region
was amplified (for PCR primers, see Table S3) and cloned into the
pGL3-Basic luciferase reporter vector (Promega, Madison, WI)
using the SmaI and KpnI sites of the multiple cloning region
[35]. To generate mutant promoter/reporter constructs, the SRY
binding consensus sites in the promoter were mutated using
complementary oligos (Table S3). Mutagenesis was performed
using i-proof Taq polymerase (BioRad) according to the ma-
nufacturer’s directions. All constructed promoter vectors were
sequence verified. Mouse Sry and Sox9 expression vectors were
generously gifted by Dr. Peter Koopman (University of Queens-
land, Australia) to M.K.S. Rat Sry expression construct was
prepared as described [20]. Briefly, a full length rat Sry expression
plasmid with a MYC tag was produced by amplifying the single
exon from rat genomic DNA and cloned into pCMV-MYC
expression vectors (Clontech, Mountain View, CA) using the BglII
and NotI restriction sites. In order to prepare recombinant rat
SRY protein, Myc-tagged rat SRY coding region was inserted into
pcDNA 3.1 vector and in vitro transcribed & translated using a
TnT T7 quick in vitro Transcription and Translation kit (Promega).
Cell Preparation and Culture
Sertoli cell culture. All cell preparation and transfections
were performed according to the protocol developed in the
laboratory as previously described [36]. All animal procedures and
protocols were approved by the Washington State University
Animal Care and Use Committee. Decapsulated testes were
minced with razor blades. Fragments were then digested with
trypsin (1.5 mg/ml, Life Technologies, Gaithersburg, MD) to
remove the interstitial cells followed by collagenase (1 mg/ml type
I, Sigma) for removal of peritubular cells and then hyaluronidase
(1 mg/ml, Sigma) for removal of germ cells. Sertoli cells were
plated under serum free conditions in 24-well Tissue Culture
Plates (Falcon Plastics, Oxnard, CA) at 1610
6 cells/well. Cells
were maintained in 5% CO2 atmosphere in Ham’s F-12 medium
(HyClone) at 32uC [37].
E13 testis cell culture. E13 embryos (12 to 18 tail somite-
stage) were collected from timed-pregnant females as described
above [34,38]. Gonads from E13 animals were dissected and each
pair of gonads from individual animals was placed into one well of
a 24 well plate with 500 ml Ham F-12 medium until embryos
could be sexed as described above. The male gonads were then
pooled and digested with trypsin (2.5%) and collagenase (1 mg/ml
type I) plus DNase (3 mg/ml) to disassociate the cells. All the cells
from the digested testes were then cultured on 100 mm plates
in Ham’s F-12 with 10% bovine calf serum (Sigma). Cells ini-
tially multiplied well in culture and were split two times (1:2) as
they reached confluence, at which point cell division slowed
considerably. Cells were maintained in culture, changing me-
dium every three days, until growth plaques were observed at
approximately one month. These growth plaques were then col-
lected for further propagation and frozen stocks were prepared for
subsequent cell splitting such that cells could be maintained at
fewer than 12 subcultures. E13 female primary cells were also
prepared accordingly using female gonads from E13 (14 to 18 tail
somite-stage female embryos).
Transfection Procedures
Sertoli cell transfection. Sertoli cells cultured for 48 hours
were transfected by the calcium phosphate method coupled with
hyper osmotic shock (10% glycerol) as previously described
[35,36]. Briefly, 2 mg promoter reporter plasmid with or without
1 mg expression plasmid in 150 ml transfection buffer (250 mM
CaCl2 mixed 1:1 (v:v) with 26 HEBES (28 mM NaCl, 50 mM
HEPES, and 1.47 mM Na2HPO4 at pH 7.05)) was added to each
well of a 24 well plate containing 1610
6 Sertoli cells in 1 ml
Ham’s F-12 medium and incubated at 32uC for 3.5 hours.
Following incubation, the cells were subjected to hyper-osmotic
shock. The medium was aspirated and 1 ml of 10% glycerol in
Hanks’ Balanced Salt Solution (HBSS, Invitrogen) was added for
3 minutes. Wells were washed twice in HBSS before fresh Ham’s
F-12 with 0.01% BSA was added. Following a 72 hour incubation
cells were harvested for luciferase assays. Medium was aspirated
and 100 mlo f1 6cell lysis solution (Promega) was added per well.
Plates were frozen and thawed before cell lysate was collected. For
detection of luciferase reporter activity 20 ml of Sertoli cell lysate
was mixed with 100 ml of luciferase substrate (Promega) and
luciferase activity detected on a Wallac Victor II 1420 instrument.
E13 cultured testis cell transfection. Cells between sub 8
and 12 were transfected using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) [39]. Two mg promoter reporter plasmid with or
without 0.5 mg expression plasmid was mixed with 2 ml
Lipofectamine 2000 in 100 ml Opti-MEM medium (Invitrogen)
for each well of a 24 well plate. This 100 ml mix was added to each
well containing ,90% confluent cultured E13 testis cells in 1 ml
Ham’s F-12 medium without antibiotics and incubated at 32uC for
24 hours. After 24 hours medium was aspirated from cells and
replaced with 1 ml Ham’s F-12 with 10% serum. Cells were in-
cubated 72 hours and collected for luciferase assays as described
above for Sertoli cells. For over-expression, cells were transfected
in 6 well plates with 4 mg expression construct for TCF21-pCMV-
myc, rat SRY-pCMV-myc and rat TCF12-pCMV-HA. Cells were
collected after 6 days and RNA was extracted using Trizol. RNA
was reverse transcribed and cDNA was used for PCR. At least
three over-expression experiments were made with both E13 male
and female cell cultures.
Immunoprecipitation Pull-Down Assay
SRY recombinant protein with HA tag was synthesized in vitro
by using Sry expression construct and an in vitro transcription
and translation kit according to the manufacturer’s instruction
(Promega) [40]. Oligonucleotides corresponding to Tcf21 promot-
er with or without SRY binding site were generated by PCR
amplification with primers listed in the Table S3. DNA-protein
binding was performed in 30 ul reaction mixture containing
100 mM KCl, 1 mM MgCl2,1 0 mM ZnSO4, 10 mM Tris,
pH 7.5, 4% glycerol, 0.1% Triton X-100, 1 mg/mL BSA, 1 mg
of poly(dIdC)/poly(dAdT), 0.5 mM DTT and protease inhibitor
cocktail mini tabs (Sigma). Binding reaction continued for an hour
at room temperature. Protein-A Sepharose beads were preswollen
in the cChIP incubation buffer (50 mM Nacl, 20 mM Tris HCl
pH 7.5, 20 mM Na-butyrate, and 5 mM EDTA) overnight.
Before use, beads were incubated with anti-HA antibody or
with non-immune IgG as a negative control. Following gentle
centrifugation (6006 g) for 5 minutes, beads were treated with
protein-oligo mixture and incubated with gentle rotation overnight
at 4 degree Celsius. In this way the antibodies, while bound to the
beads, would attach to their matching proteins and capture the
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washed three times with wash buffer containing 50 mM, 100 mM
and 150 mM NaCl. Pulled-down oligos were eluted in a buffer
containing 0.5% SDS and purified in PCR purification columns
according to manufacturer’s instruction (Promega). Purified oligo
DNA was subjected to PCR with primers designed to flank that
particular sequence of Tcf21 promoter.
Chromatin Immunoprecipitation (ChIP) Assay
In vivo. Carrier ChIP (cChIP) assay was adopted from
O’Neill et al., (2006) [26] and conditions were modified to meet
the condition for immunoprecipitating SRY. To run ChIP assay,
male and female gonads (gonad+mesonephros) were dissected
from approximately twenty to twenty five 13 dpc (12–18 tail
somite stage) rat embryos per array and snap-frozen in liquid
nitrogen. Drosophila SL2 cells were used as a carrier. Densely-
grown cells (approximately 5610
7 cells) were pelleted and washed
three times in ice-cold PBS, 5 mM sodium butyrate and
resuspended in 0.5 ml NB buffer (15 mM Tris-HCL, pH 7.4,
60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 0.1 mM EGTA,
0.5 mM 2-mercaptoethanol, 0.1 mM PMSF). Frozen testis
samples were thawed, mixed with SL2 cells and homogenized to
make single cell suspension. Nuclei were pelleted, resuspended in
20 ml NB buffer, 5% (vol/vol) sucrose, pelleted and resuspended
again in 5 ml digestion buffer (50 mM Tris-HCl pH 7.4, 0.32 M
sucrose, 4 mM MgCl2, 1 mM CaCl2, 0.1 mM PMSF). Following
micrococcal nuclease digestion (NEB, USA) for 10 minutes at 37
degree, the digested samples were gently spun (8006g) for
10 minutes and supernatant set aside on ice. The pellet was
resuspended in 250 ul incubation buffer (50 mM Nacl, 20 mM
Tris HCl pH 7.5, 20 mM Na-butyrate, 5 mM Na2EDTA, and
0.1 mM PMSF) and again centrifuged gently for 10 minutes. Both
the supernatants were pooled and a fraction (50 ul) out of it was
kept aside to use as input. The remaining supernatant was
incubated with either non-immune IgG or anti-SRY or anti-Gata4
antibodies at 4uC overnight. After incubation with 100 mlo f
preswollen protein A-Sepharose beads (Sigma) for 2 h at 4uC, the
bead-bound immunoprecipitates were centrifuged gently and
washed five times with wash buffer (50 mM TrisHCl pH 7.5,
10 mM EDTA, 5 mM Na butyrate and 50–150 mM NaCl). The
protein-DNA complexes were incubated at room temperature
with elution buffer (1% SDS in TE) and centrifuged at 115006ga t
4uC for 10 minutes. Elution was repeated two times and eluted
DNA was pooled. Co-immunoprecipitated DNA was purified by
proteinase K digestion, phenol/chloroform extraction, and
ethanol precipitation. Final concentration of immunoprecipitated
DNA varied from 100 to 300 ng per assay. Two rounds of PCR
reactions were run for 25 cycles before evaluating samples by gel
electrophoresis. Identity of the PCR-amplified fragments was
verified by sequencing. Primers used to investigate the enrichment
of Tcf21 promoter fragments by PCR are listed in Table S3.
Microarray Analysis
mRNA processing and hybridization were performed at
Genomics Core Laboratory, Center for Reproductive Biology,
Washington State University, Pullman, WA using standard
Affymetrix reagents and protocol [41]. Briefly, mRNA was
transcribed into cDNA with random primers, from the later,
cRNA was transcribed, and from that, single-stranded sense DNA
was synthesized which was fragmented and labeled with biotin.
Biotin-labeled fragmented ssDNA was then hybridized to the Rat
Gene 1.0 ST microarrays containing more than 27,000 transcripts
(Affymetrix, Santa Clara, CA, USA). Hybridized chips were
scanned on Affymetrix Scanner 3000. CEL files containing raw
data were then pre-processed and analyzed with Partek Genomic
Suite 6.5 beta software (Partek Inc, St. Louis, MO) using RMA,
GC-content adjusted algorithm. Lists of differentially expressed
genes treatment were generated using following cut off criteria:
signal ratio Control/Treatment .1.20 or ,0.83, mean difference
for un-logged signals between control and treatment .10, t-test p-
values,0.05. CEL files from this study have been deposited with
the NCBI gene expression and hybridization array data repository
(GEO, http://www.ncbi.nlm.nih.gov/geo, #GSE# GSE24666
and can be also accessed through www.skinner.wsu.edu, and is
MIAME compliant. For genes annotation, Affymetrix annotation
file RaGene1_0stv1.na30.rn4.transcript.csv was used unless oth-
erwise specified. Generation of affected KEGG pathways (Kyoto
Encyclopedia for Genes and Genome, Kyoto University, Japan)
used Pathway-Express, a web-based tool freely available as part of
the Onto-Tools (http://vortex.cs.wayne.edu) [42]. Previous stud-
ies have demonstrated that microarray data are validated with
quantitative PCR data [38,43]. Due to the presence of 11 different
oligonucleotide sets for each specific gene being used on the
microarray versus only a single primer set for a gene in a
quantitative PCR, the microarray is more effective at eliminating
false positive or negative data and provides a more robust
quantification of changes in gene expression.
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